Proposition of treatment to improve the immune response: possible application to AIDS.
The molecular similarity between certain human antigenic determinants with those of HIV has been already described. In this matter, we have previously demonstrated, by a chromatographic method, the cross reactivity of human serum albumin with HIV gp 120. The hypothesis that this similarity could be one of the reasons why the virus escapes to the immune system is presented in this paper and a treatment is proposed to enhance the efficiency of the immune response: it is based on the blocking of the determinants of the self, expressed in the thymus, which are in common with the virus. Repeated injections within the thymus of neutralizing antibodies against the pathogen, obtained from a sufficiently distant animal species and purified by affinity chromatography, would prevent the T cells of the host recognizing these epitopes, common to the host and to the virus, from clonal deletion and would improve the immune response.
Berger
G
G
Perigny sur Yerres, France.
D016915:AIDS Vaccines / Q000494:pharmacology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000628:therapy*; D000818:Animals; D001324:Autoantigens; D003429:Cross Reactions; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D018448:Models, Immunological; D009500:Neutralization Tests; D012709:Serum Albumin / Q000276:immunology
D016915:AIDS Vaccines; D001324:Autoantigens; D015699:HIV Envelope Protein gp120; D012709:Serum Albumin